AURKB and lung cancer: In agreement with this, overexpression of Aurora-A and/or Aurora-B has been shown to associate with a poor prognosis in several human malignancies, including breast, gastric, prostate, head and neck, bladder, ovarian, colon, adrenocortical and lung cancers [24–31].